Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
Citi
Accenture
Express Scripts
Daiichi Sankyo
Harvard Business School
Baxter
McKinsey
AstraZeneca

Generated: October 18, 2017

DrugPatentWatch Database Preview

EMGEL Drug Profile

« Back to Dashboard

What is the patent landscape for Emgel, and when can generic versions of Emgel launch?

Emgel is a drug marketed by Altana and is included in one NDA.

The generic ingredient in EMGEL is erythromycin. There are ninety-nine drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the erythromycin profile page.

Summary for Tradename: EMGEL

US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list42
Patent Applications: see list7,615
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:EMGEL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Altana
EMGEL
erythromycin
GEL;TOPICAL063107-001Aug 23, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
McKinsey
Deloitte
McKesson
Daiichi Sankyo
Citi
Medtronic
Harvard Business School
US Department of Justice
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot